株式会社PRISM BioLab、13億円のシリーズC資金調達を実施

お知らせ

PRISM BioLab, the Japan based biotechnology company with proprietary small molecule drug discovery technology ”PepMetics®”, today announced that it has raised a total of ¥1.3 billion in Series C funding on August 27.

 詳細はこちら

Back to Home

>